Genus plc (LON:GNS)
2,890.00
-280.00 (-8.83%)
Feb 26, 2026, 2:49 PM GMT
Genus Revenue
Genus had revenue of 336.40M GBP in the half year ending June 30, 2025, a decrease of -0.91%. This brings the company's revenue in the last twelve months to 672.00M, up 0.06% year-over-year. In the fiscal year ending June 30, 2025, Genus had annual revenue of 672.80M with 0.60% growth.
Revenue (ttm)
672.00M
Revenue Growth
+0.06%
P/S Ratio
3.15
Revenue / Employee
210.91K
Employees
3,190
Market Cap
2.12B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 672.80M | 4.00M | 0.60% |
| Jun 30, 2024 | 668.80M | -20.90M | -3.03% |
| Jun 30, 2023 | 689.70M | 96.30M | 16.23% |
| Jun 30, 2022 | 593.40M | 19.10M | 3.33% |
| Jun 30, 2021 | 574.30M | 22.90M | 4.15% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Oxford Nanopore Technologies | 204.69M |
| Oxford Biomedica | 151.21M |
| hVIVO | 54.47M |
| Bioventix | 13.12M |
| Scancell Holdings | 4.71M |
| PureTech Health | 4.66M |
| 4basebio | 1.78M |
| Ondine Biomedical | 1.18M |
Genus News
- 2 hours ago - Genus plc 2026 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 7 days ago - Genius Group (GNS) Reveals Ambitious 2026 Growth Strategy - GuruFocus
- 22 days ago - Genius Group (GNS) Partners with ReadyNest to Launch Innovative AI Education Capsules - GuruFocus
- 4 weeks ago - Genus Plc: A Uniquely Positioned, Under-Appreciated Animal Genetics Company - Seeking Alpha
- 5 weeks ago - UK animal genetics firm Genus surges on annual profit forecast upgrade - Reuters
- 6 months ago - Genus Plc (GENSY) Q4 2025 Earnings Call Prepared Remarks Transcript - Seeking Alpha
- 6 months ago - British animal genetics firm Genus surges on strong annual profit growth - Reuters
- 10 months ago - UK's Genus secures FDA approval for PRP gene edit; shares soar - Reuters